SCoV-2 Detect IgG ELISA

Manufactured by InBios International, United States - inbios.com/

Device identification number

1409

CE Marking

✓Yes

HSC common list (RAT)

×No

Format

Lab-based

Physical Support

Microplate

Target type

Antibody, IgG

Specimen

Serum

Commercial Status

Commercialised

Last Update

2022-08-24 09:08:01 CET

Comments

https://inbios.com/scov-2-detect-igg-elisa-kit-2/

Assay Type

Immuno-Antibody

Rapid Diagnostic

Reader Required

Yes

Method

ELISA

Measurement

Qualitative

Time

150 minutes

Detection Principle

Magnetic Electrochemical

Analysis of cross reactivity

0 % IgG for tested agents

Clinical Sensitivity

97.8 % IgG

Clinical Specificity

98.95 % IgG

Related Scientific Literature

Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing
Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements

COVID-19 In Vitro Diagnostic Medical Device - detail

Related Scientific Literature